ReNerve has never been listed on the ASX.
Its had a few earlier funding rounds to get it to this stage.
Compares well to Orthocell (OCC) with a market cap of $135 mil.
ReNerve will have an EV of $20 mil and is arguably further advanced than Orthocell.
Dr Julian Chick is the MD and he is also a Director of LTP which has been massively successful as an IPO.
I suspect that investors will be hoping for more of the same here.
Looking good.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $11.02M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $13.61K | 127.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 148 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 136000 | 3 |
View Market Depth
| Last trade - 14.57pm 25/07/2025 (20 minute delay) ? |
| RNV (ASX) Chart |